2022 | Interferon-gamma Release Assay Results Are Reliable for Screening for Latent Tuberculosis in Antineutrophil Cytoplasmic Antibody-associated Vasculitis
| IN VIVO |
2022 | BVAS version 3 and BVAS/GPA: standing on the same line? | CLINICAL RHEUMATOLOGY |
2022 | Assessment of disease activity in patients with rheumatoid arthritis using plasma tumour M2-pyruvate kinase test
| FRONTIERS IN IMMUNOLOGY |
2022 | Serum glycated albumin as a predictive biomarker for renal involvement of antineutrophil cytoplasmic antibody-associated vasculitis in non-diabetic patients
| BMC NEPHROLOGY |
2022 | Nutrition Risk Index Score at Diagnosis Can Effectively Predict Poor Prognosis in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis | JOURNAL OF RENAL NUTRITION |
2022 | Modified Body Mass Index at Diagnosis is a Useful Predictor of Mortality in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis
| Journal of Rheumatic Diseases |
2022 | Predicting the depressive status using empirical dietary inflammatory index in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| JOURNAL OF CLINICAL LABORATORY ANALYSIS |
2022 | A positive faecal immunochemical test result and its association with the incidence of rheumatoid arthritis, systemic lupus erythematosus, and psoriatic arthritis: an analysis of one-million national colorectal cancer screening programme results
| BMC MEDICINE |
2022 | Secular Trends of Incidence, Prevalence, and Healthcare Economic Burden in ANCA-Associated Vasculitis: An Analysis of the 2002-2018 South Korea National Health Insurance Database
| FRONTIERS IN MEDICINE |
2022 | Serum albumin, prealbumin, and ischemia-modified albumin levels in patients with ANCA-associated vasculitis: A prospective cohort study
| PLOS ONE |
2022 | Fatty Liver Index Independently Predicts All-Cause Mortality in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis but No Substantial Liver Disease
| FRONTIERS IN CARDIOVASCULAR MEDICINE |
2022 | Triglyceride and Glucose Index Predicts Acute Coronary Syndrome in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| DIAGNOSTICS |
2022 | Association of serum hepatoma-derived growth factor levels with disease activity in rheumatoid arthritis: A pilot study
| JOURNAL OF CLINICAL LABORATORY ANALYSIS |
2022 | Serum galectin-9 could be a potential biomarker in assessing the disease activity of antineutrophil cytoplasmic antibody-associated vasculitis
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
2022 | Effect of numbers of metabolic syndrome components on mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis with metabolic syndrome
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
2022 | New body mass index for predicting prognosis in patients with antineutrophil cytoplasmic antibody-associated vasculitis
| JOURNAL OF CLINICAL LABORATORY ANALYSIS |
2022 | Incidence and Patterns of Interstitial Lung Disease and Their Clinical Impact on Mortality in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Korean Single-Centre Observational Study
| JOURNAL OF IMMUNOLOGY RESEARCH |
2022 | Incidence, prevalence and risk of stroke in patients with Takayasu arteritis: a nationwide population-based study in South Korea
| STROKE AND VASCULAR NEUROLOGY |
2022 | Anti-Citrullinated Peptide Antibody Expression and Its Association with Clinical Features and Outcomes in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| MEDICINA-LITHUANIA |
2022 | Rheumatoid factor positivity in antineutrophil cytoplasmic antibody-associated vasculitis: a distinct clinical entity or innocent bystander? | RHEUMATOLOGY |
2022 | Clinical characteristics and long-term outcomes in patients with mixed Class III/IV + V and pure proliferative lupus nephritis: A single-center experience | LUPUS |
2022 | Clinical Features of Anti-Synthetase Syndrome Associated with Prognosis in Patients with Dermatomyositis and Polymyositis
| JOURNAL OF CLINICAL MEDICINE |
2022 | Aortic valve surgery in patients with Takayasu's arteritis: a nationwide analysis of 1,197 patients during a 9-year period
| CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
2022 | A retrospective analysis of antineutrophil cytoplasmic antibody-associated vasculitis aiming for an equation prediction end-stage renal disease | CLINICAL RHEUMATOLOGY |
2022 | Serum vitamin D level correlates with disease activity and health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis | ZEITSCHRIFT FUR RHEUMATOLOGIE |
2022 | Association Between Idiopathic Cutaneous Leukocytoclastic Angiitis and ANCA-negative Microscopic Polyangiitis
| Journal of Rheumatic Diseases |
2021 | Metabolic Syndrome Severity Score, Comparable to Serum Creatinine, Could Predict the Occurrence of End-Stage Kidney Disease in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| JOURNAL OF CLINICAL MEDICINE |
2021 | Serum progranulin as a predictive marker for high activity of antineutrophil cytoplasmic antibody-associated vasculitis
| JOURNAL OF CLINICAL LABORATORY ANALYSIS |
2021 | Serum Clusterin Level Could Reflect the Current Activity of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| YONSEI MEDICAL JOURNAL |
2021 | Clinical significance of large unstained cell count in estimating the current activity of antineutrophil cytoplasmic antibody-associated vasculitis | INTERNATIONAL JOURNAL OF CLINICAL PRACTICE |
2021 | Frequency and Factors of Indeterminate QuantiFERON-TB Gold In-Tube and QuantiFERON-TB Gold PLUS Test Results in Rheumatic Diseases
| JOURNAL OF CLINICAL MEDICINE |
2021 | Evaluation of body composition using computed tomography in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis
| KOREAN JOURNAL OF INTERNAL MEDICINE |
2021 | Correlation between serum cysteine-rich protein 61 and disease activity of antineutrophil cytoplasmic antibody-associated vasculitis | CLINICAL RHEUMATOLOGY |
2021 | Efficacy of tacrolimus as maintenance therapy after cyclophosphamide for treating antineutrophil cytoplasmic antibody-associated vasculitis
| MEDICINE |
2021 | Systemic inflammation response index predicts all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis | INTERNATIONAL UROLOGY AND NEPHROLOGY |
2021 | Significance of antineutrophil cytoplasmic antibody positivity in patients with systemic sclerosis: a single-centre pilot study in Korea | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
2021 | Predictive Ability of Serum IL-27 Level for Assessing Activity of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
| MEDIATORS OF INFLAMMATION |
2021 | Serum adipokine profiles in patients with microscopic polyangiitis and granulomatosis with polyangiitis: An exploratory analysis | PLOS ONE |
2021 | The Efficacy of Mycophenolate Mofetil in Remission Maintenance Therapy for Microscopic Polyangiitis and Granulomatosis with Polyangiitis
| YONSEI MEDICAL JOURNAL |
2021 | Male Sex Is a Significant Predictor of All-cause Mortality in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2021 | Association Between Serum Alarmin Levels and Disease-specific Indices in Patients With Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis | IN VIVO |
2021 | Total Haemolytic Complement Activity at Diagnosis as an Indicator of the Baseline Activity of Antineutrophil Cytoplasmic Antibody-associated Vasculitis
| Journal of Rheumatic Diseases |
2021 | Association between follistatin-related protein 1 and the functional status of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis
| CHINESE MEDICAL JOURNAL |
2021 | Fibrinogen to albumin ratio reflects the activity of antineutrophil cytoplasmic antibody-associated vasculitis
| JOURNAL OF CLINICAL LABORATORY ANALYSIS |
2021 | The novel fibrosis index at diagnosis may predict all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis without substantial liver diseases
| CLINICS |
2021 | Efficacy of the fibrosis index for predicting end-stage renal disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis | INTERNATIONAL JOURNAL OF CLINICAL PRACTICE |
2021 | Serological Biomarkers and Indices for the Current Activity and Prognosis of ANCA-Associated Vasculitis: Experience in a Single Centre in Korea
| YONSEI MEDICAL JOURNAL |
2021 | Pan-immune-inflammation value at diagnosis independently predicts all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY |
2021 | Risk of Stroke in Systemic Necrotizing Vasculitis: A Nationwide Study Using the National Claims Database
| FRONTIERS IN IMMUNOLOGY |
2021 | Reclassification of Korean patients with polymyositis and dermatomyositis based on the Bohan and Peter criteria by the 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies
| KOREAN JOURNAL OF INTERNAL MEDICINE |